Last Updated: September 24, 2026

Details for New Drug Application (NDA): 209732

✉ Email this page to a colleague

« Back to Dashboard

NDA 209732 describes PERMETHRIN, which is a drug marketed by Actavis Labs, Dr Reddys Labs Eu, Encube Ethicals, Padagis Israel, Actavis Mid Atlantic, and Perrigo New York, and is included in six NDAs. It is available from ten suppliers. Additional details are available on the PERMETHRIN profile page.

The generic ingredient in PERMETHRIN is permethrin. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the permethrin profile page.

Summary for 209732

Tradename:	PERMETHRIN
Applicant:	Dr Reddys Labs Eu
Ingredient:	permethrin
Patents:	0

Pharmacology for NDA: 209732

Medical Subject Heading (MeSH) Categories for 209732

Enzyme Inhibitors
Insecticides

Suppliers and Packaging for NDA: 209732

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
PERMETHRIN	permethrin	CREAM;TOPICAL	209732	ANDA	Dr. Reddy's Laboratories, Inc.	43598-481	43598-481-60	1 TUBE in 1 CARTON (43598-481-60) / 60 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CREAM;TOPICAL			Strength	5%
Approval Date:	Aug 1, 2023	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.